مرکز اطلاعات علمی Scientific Information Database (SID) - Trusted Source for Research and Academic Resources

Persian Verion

مرکز اطلاعات علمی Scientific Information Database (SID) - Trusted Source for Research and Academic Resources

video

مرکز اطلاعات علمی Scientific Information Database (SID) - Trusted Source for Research and Academic Resources

sound

مرکز اطلاعات علمی Scientific Information Database (SID) - Trusted Source for Research and Academic Resources

Persian Version

مرکز اطلاعات علمی Scientific Information Database (SID) - Trusted Source for Research and Academic Resources

View:

530
مرکز اطلاعات علمی Scientific Information Database (SID) - Trusted Source for Research and Academic Resources

Download:

0
مرکز اطلاعات علمی Scientific Information Database (SID) - Trusted Source for Research and Academic Resources

Cites:

Information Journal Paper

Title

A Comprehensive Review on Medication Used for Warfarin Reversal

Pages

  67-73

Abstract

Warfarin sodium as an anticoagulant, is widely used for the prevention and treatment of venous and arterial thrombosis. As a Vitamin K antagonist, Warfarin effectively decreases the hepatic production of clotting factors II, VII, IX, and X, along with proteins C and S. While anticoagulants such as Warfarin have well-established indications, they are also associated with few side effects such as haemorrhage. Many patients receiving Vitamin K antagonists have an International Normalized Ratio (INR) higher than the target of 2. 0 to 3. 0 for over 50% of the time, which is followed with increasing risk of bleeding. In this situation the clinical need for emergency reversal of anticoagulation is necessary. There are a number of potential treatment options for anticoagulant reversal, including administration of Vitamin K (oral or intravenous), human plasma products [for example, Fresh Frozen Plasma (FFP)], prothrombin complex concentrates (PCCs); concentrates that contain coagu-lation factors II, VII, IX and X), or single coagulation factors such as activated re-combinant factor VII (rFVIIa). The aim of this paper was to conduct a review of the medical literature and summarize the advantages and risks of the available treatment options for reversing Warfarin anticoagulation in patients receiving Warfarin.

Cites

  • No record.
  • References

  • No record.
  • Cite

    APA: Copy

    GHAFARI, SOMAYEH, & HAJHOSEINTALASAZ, AZITA. (2018). A Comprehensive Review on Medication Used for Warfarin Reversal. JOURNAL OF MEDICAL COUNCIL OF I.R.I., 36(2 ), 67-73. SID. https://sid.ir/paper/41383/en

    Vancouver: Copy

    GHAFARI SOMAYEH, HAJHOSEINTALASAZ AZITA. A Comprehensive Review on Medication Used for Warfarin Reversal. JOURNAL OF MEDICAL COUNCIL OF I.R.I.[Internet]. 2018;36(2 ):67-73. Available from: https://sid.ir/paper/41383/en

    IEEE: Copy

    SOMAYEH GHAFARI, and AZITA HAJHOSEINTALASAZ, “A Comprehensive Review on Medication Used for Warfarin Reversal,” JOURNAL OF MEDICAL COUNCIL OF I.R.I., vol. 36, no. 2 , pp. 67–73, 2018, [Online]. Available: https://sid.ir/paper/41383/en

    Related Journal Papers

    Related Seminar Papers

  • No record.
  • Related Plans

  • No record.
  • Recommended Workshops






    Move to top
    telegram sharing button
    whatsapp sharing button
    linkedin sharing button
    twitter sharing button
    email sharing button
    email sharing button
    email sharing button
    sharethis sharing button